Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL611025

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
C[C@H]1[C@@H](OC/C=C\CO[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]1[C@@]24OO3
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL611025
Phase Preclinical
Structure Type MOL
InChI Key FYPHPAIHOJTHRN-KWTFITEKSA-N
4
Targets
5
Activities
1
Assay Types
0
PK Parameters
18
Publications
0
Known Names

Molecular Properties

620.8
MW (Da)
5.99
ALogP
10
HBA
0
HBD
92.3
PSA (Ų)
0.26
QED
2
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C34H52O10
MW 620.78
Aromatic Rings 0
Heavy Atoms 44
NP-Likeness 1.88

Activity Summary

IC50 5 meas. best 8.21

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Plasmodium falciparum
CHEMBL364
 IC50 8.21 8.205 6.1 2
KB
CHEMBL398
 IC50 6.5 6.5 320.0 1
BT-549
CHEMBL614072
 IC50 5.82 5.82 1530.0 1
Cryptococcus neoformans
CHEMBL365
 IC50 4.62 4.62 24160.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Plasmodium falciparum IC50 = 6.1 nM 8.21 Antiplasmodial activity against Plasmodium falciparum W2 infected in RBCs by par... 19879765
Plasmodium falciparum IC50 = 6.3 nM 8.2 Antiplasmodial activity against Plasmodium falciparum D6 infected in RBCs by par... 19879765
KB IC50 = 320.0 nM 6.5 Cytotoxicity against human KB cells after 48 hrs by neutral red assay 19879765
BT-549 IC50 = 1530.0 nM 5.82 Cytotoxicity against human BT549 cells after 48 hrs by neutral red assay 19879765
Cryptococcus neoformans IC50 = 24160.0 nM 4.62 Antifungal activity against Cryptococcus neoformans ATCC 90113 by modified CLSI/... 19879765

Literature References

PubMed DOI Target Context # Activities
19879765 10.1016/j.bmc.2009.10.019 Leishmania donovani 2
19879765 10.1016/j.bmc.2009.10.019 Vero 2
19879765 10.1016/j.bmc.2009.10.019 Unchecked 2
19879765 10.1016/j.bmc.2009.10.019 Staphylococcus aureus 2
19879765 10.1016/j.bmc.2009.10.019 Plasmodium falciparum 2
19879765 10.1016/j.bmc.2009.10.019 KB 1
19879765 10.1016/j.bmc.2009.10.019 ADMET 1
19879765 10.1016/j.bmc.2009.10.019 BT-549 1
19879765 10.1016/j.bmc.2009.10.019 Pichia kudriavzevii 1
19879765 10.1016/j.bmc.2009.10.019 Nakaseomyces glabratus 1
19879765 10.1016/j.bmc.2009.10.019 Mycobacterium intracellulare 1
19879765 10.1016/j.bmc.2009.10.019 Pseudomonas aeruginosa 1
19879765 10.1016/j.bmc.2009.10.019 Escherichia coli 1
19879765 10.1016/j.bmc.2009.10.019 Aspergillus fumigatus 1
19879765 10.1016/j.bmc.2009.10.019 Candida albicans 1
19879765 10.1016/j.bmc.2009.10.019 SK-OV-3 1
19879765 10.1016/j.bmc.2009.10.019 SK-MEL 1
19879765 10.1016/j.bmc.2009.10.019 Cryptococcus neoformans 1

Data from ChEMBL 36 via Core Engine